Yan et al. demonstrated that deregulated miR-335 that targets MAPK1 was implicated in poor outcome of pediatric acute lymphoblastic leukemia [28, 39, 40]. This evidence concerns the gene MAPK1 and acute lymphoblastic leukemia.